StockData
PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc. (PTCT) stock

PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.36−0.61 (-1.00%)

Close on Nov 17, 2026Market cap $5.04BP/E –Yield –

PTC Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

PTC Therapeutics's price to book ratio was 27.1× on Jan 31, 2022, against 7.7× a year earlier. Over the last 5 years it ranged from 2.8× to 27.1×, with a median of 5.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202227.1×+0.3
2021Dec 31, 202126.8×+18.7
2020Dec 31, 20208.1×+3.6
2019Dec 31, 20194.5×−0.0
2018Dec 31, 20184.5×−0.3
2017Dec 29, 20174.7×+2.1
2016Dec 30, 20162.7×−1.4
2015Dec 31, 20154.1×−3.5
2014Dec 31, 20147.6×+4.9
2013Dec 31, 20132.7×–

More PTC Therapeutics figures

See a number that looks wrong?